Department of Medicine, The University of Melbourne, Melbourne, Australia.
Department of Gastroenterology, St. Vincent's Hospital Melbourne, Melbourne, Australia.
Inflamm Bowel Dis. 2022 Aug 1;28(8):1177-1188. doi: 10.1093/ibd/izab247.
Preventive health measures reduce treatment and disease-related complications including infections, osteoporosis, and malignancies in patients with inflammatory bowel disease (IBD). Although guidelines and quality measures for IBD care highlight the importance of preventive care, their uptake remains variable. This systematic review evaluates interventions aimed at improving the rates of provision and uptake of preventive health measures, including vaccinations, bone density assessment, skin cancer screening, cervical cancer screening, and smoking cessation counseling.
We searched PubMed, MEDLINE, EMBASE, and CENTRAL for full text articles published until March 2021. Studies were included if they evaluated interventions to improve the provision or uptake of 1 or more preventive health measures in adult IBD patients and if they reported pre- and postintervention outcomes.
In all, 4655 studies were screened, and a total of 17 studies were included, including 1 randomized controlled trial, 1 cluster-controlled trial, and 15 prospective interventional studies. A variety of interventions were effective in improving the rates of adherence to preventive health measures. The most common interventions targeted gastroenterologists, including education, electronic medical records tools, and audit feedback. Other interventions targeted patients, such as education, questionnaires, and offering vaccine administration at clinic visits. Few interventions involved IBD nurses or primary care physicians.
A range of interventions-targeted at gastroenterologists, patients, or both-were effective in improving the provision and uptake of preventive care. Future studies should involve randomized controlled trials evaluating multifaceted interventions that target barriers to adherence and involve IBD nurses and primary care physicians.
预防措施可减少炎症性肠病(IBD)患者的治疗和疾病相关并发症,包括感染、骨质疏松症和恶性肿瘤。尽管 IBD 护理的指南和质量标准强调了预防保健的重要性,但它们的实施情况仍存在差异。本系统评价评估了旨在提高预防保健措施(包括疫苗接种、骨密度评估、皮肤癌筛查、宫颈癌筛查和戒烟咨询)提供和采用率的干预措施。
我们检索了截至 2021 年 3 月的 PubMed、MEDLINE、EMBASE 和 CENTRAL 的全文文章。如果研究评估了旨在提高成年 IBD 患者 1 种或多种预防保健措施的提供或采用率的干预措施,并且报告了干预前后的结果,则纳入研究。
共筛选了 4655 篇研究,共纳入 17 项研究,包括 1 项随机对照试验、1 项聚类对照试验和 15 项前瞻性干预研究。多种干预措施有效提高了预防保健措施的依从率。最常见的干预措施针对胃肠病学家,包括教育、电子病历工具和审核反馈。其他针对患者的干预措施,如教育、问卷调查和在就诊时提供疫苗接种。很少有干预措施涉及 IBD 护士或初级保健医生。
针对胃肠病学家、患者或两者的一系列干预措施可有效提高预防保健的提供和采用率。未来的研究应包括评估针对依从性障碍并涉及 IBD 护士和初级保健医生的多方面干预措施的随机对照试验。